IIPLA News
Monday, June 8, 2026

Former Goodwin Partners Launch AI-Driven IP Law Firm Targeting Life Sciences Startups

Antheros integrates generative AI to streamline intellectual property workflows and offers subscription billing to early-stage companies

IIPLA News Deskanonymous access0 articles left this week
Former Goodwin Partners Launch AI-Driven IP Law Firm Targeting Life Sciences Startups

Antheros, a San Francisco-based law firm founded in 2025, represents a new wave of AI-native legal practices designed to transform intellectual property services for early-stage life sciences companies. The firm was established by three former Goodwin Procter IP attorneys: partners Sabrina Poulos and Kristin Havranek, and associate Stephanie Dusaban Gonzales. All three also previously worked at Wilson Sonsini Goodrich & Rosati, where Poulos held a partnership role.

The founders built Antheros around the premise that intellectual property practice, which combines routine drafting and prosecution with high-level strategic decision-making, is particularly well-suited to AI integration. By automating repetitive tasks such as drafting portions of patent applications, the firm’s attorneys can dedicate more time to advising clients on broader portfolio strategies.

"There's a lot of high-level thinking, but there's also a lot of rote work in drafting up the specs and doing a lot of the prosecution," Poulos explained. "AI lets us compress that, ... and that gives us the space, the freedom and the time to really sit there and think strategically about the client's portfolio."

Antheros’s approach extends beyond legal practice to its business model. From inception, the firm designed every workflow with AI as a foundational element, influencing hiring practices and fee structures. This AI-centric design enables the firm to offer subscription-based billing, providing clients with predictable costs for IP services.

The firm’s approximately dozen-person team includes associates, patent agents, and other professionals, all working within AI-optimized workflows. The founders’ technical backgrounds—Poulos in pharmaceutical research, Havranek as a medical device engineer, and Gonzales holding a Ph.D. in biomedical sciences—inform their deep understanding of the scientific and technological nuances critical to life sciences IP.

Antheros employs enterprise AI software from providers such as Harvey, LexisNexis, and AnkarAI to build customized workflows for discrete IP tasks, including gap analysis, patent prosecution, and communications with regulatory bodies like the U.S. Patent and Trademark Office. The firm maintains a dedicated AI work team that meets weekly to evaluate tool effectiveness and adapt workflows as AI capabilities evolve.

"We know the basic buckets of everything we do within our practice and have mapped what we think are the best tools to use in those instances," Havranek said. "If something's more scientific, we might use a different tool than something that we are going to try to have some legal conclusions to, or an office action response might be best using a different tool than a drafting or a freedom to operate evaluation."

Despite the extensive use of AI, the founders emphasized that all work product undergoes attorney review. They acknowledged that significant elements of IP practice, especially in highly technical fields, require human expertise and judgment.

The emergence of Antheros reflects broader trends in the legal industry, where rapid advancements in generative AI are prompting new firm models that blend technology with traditional legal services. While many AI-native firms focus on commercial contracting, Antheros distinguishes itself by targeting the specialized needs of startups and emerging companies in life sciences, offering a full suite of transactional IP services.

By integrating AI into both legal workflows and business operations, Antheros aims to increase efficiency, reduce costs, and enhance strategic counsel for clients navigating complex intellectual property landscapes.

Share This Article
Ready-to-post copy includes the article link.

Former Goodwin Partners Launch AI-Driven IP Law Firm Targeting Life Sciences Startups Three former Goodwin Procter IP attorneys have founded Antheros, a San Francisco-based AI-native law firm focused on providing comprehensive intellectual property services to life sciences startups. By leveraging genera... Read the full IIPLA article: https://iipla.org/news/former-goodwin-partners-launch-ai-driven-ip-law-firm-targeting-life-sciences-startups

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026